Catalyst Pharmaceuticals, Inc. (CPRX)
USD 21.35
(-3.26%)
USD 21.35
(-3.26%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 143.6 Million | 116.04 Million | 60.37 Million | 45.03 Million | 34.61 Million | -25.7 Million |
| Net Income | 71.41 Million | 83.07 Million | 39.48 Million | 74.98 Million | 31.87 Million | -34 Million |
| Depreciation & Amortization | 33.14 Million | 1.23 Million | 192 Thousand | 885.31 Thousand | 297.72 Thousand | 37.97 Thousand |
| Deferred income taxes | -17.81 Million | 4.93 Million | 9.31 Million | -32.97 Million | - | - |
| Stock-based compensation | 14.25 Million | 7.9 Million | 6.07 Million | 6.26 Million | 3.82 Million | 3.55 Million |
| Change in working capital | -37.32 Million | 13.72 Million | 5.02 Million | -4.11 Million | -1.09 Million | 4.71 Million |
| Other non-cash items | 79.93 Million | 5.15 Million | 287 Thousand | -12.19 Thousand | -290.8 Thousand | 3.68 Million |
| Investing Cash Flow | -293.5 Million | 9.2 Million | -11.02 Million | -5.01 Million | 37.22 Million | -15.52 Million |
| Investments in PPE | -198.52 Million | -29 Thousand | -1.02 Million | -11.39 Thousand | -19.36 Thousand | -92.01 Thousand |
| Acquisitions | - | 10 Million | - | 5 Million | -37.24 Million | - |
| Investment purchases | -13.46 Million | -10 Million | -10 Million | -10 Million | -34.72 Million | -36.8 Million |
| Sales/Maturities of investments | - | 19.23 Million | - | 5 Million | 71.96 Million | 21.36 Million |
| Other Investing Activities | -81.51 Million | -10 Million | -10 Million | -5 Million | 37.24 Million | -14.99 Million |
| Financing Cash Flow | -10.85 Million | 1.69 Million | -8.14 Million | 701.93 Thousand | 1.11 Million | 293.11 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -982 Thousand | -7.13 Million | -12.24 Million | -56 Thousand | - | -4448.00 |
| Common Stock Issuance | 2.79 Million | 9.56 Million | 4.09 Million | 758.13 Thousand | 1.11 Million | 297.56 Thousand |
| Other Financing Activities | -9.87 Million | 8.83 Million | 4.09 Million | -197.00 | 1.11 Million | 293.11 Thousand |
| Accounts receivables | -43.07 Million | -3.82 Million | -632 Thousand | 4.54 Million | -10.53 Million | - |
| Accounts payables | 10.82 Million | 1.2 Million | -1.48 Million | 138.57 Thousand | 1.78 Million | 391.79 Thousand |
| Inventory | -4.73 Million | 1.06 Million | -3.21 Million | -2.69 Million | -1.9 Million | -56.01 Thousand |
| Other working capital | -330 Thousand | 15.27 Million | 10.36 Million | -6.1 Million | 9.56 Million | 4.37 Million |
| Cash at beginning of period | 298.39 Million | 171.44 Million | 130.23 Million | 89.51 Million | 16.55 Million | 57.49 Million |
| Cash at end of period | 137.63 Million | 298.39 Million | 171.44 Million | 130.23 Million | 89.51 Million | 16.55 Million |
| Capital Expenditure | -198.52 Million | -29 Thousand | -1.02 Million | -11.39 Thousand | -19.36 Thousand | -92.01 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -160.75 Million | 126.95 Million | 41.2 Million | 40.72 Million | 72.95 Million | -40.93 Million |
| Free Cash Flow | -54.92 Million | 116.01 Million | 59.35 Million | 45.02 Million | 34.59 Million | -25.79 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 40.79 Million | 23.27 Million | 71.41 Million | 34.84 Million | -30.76 Million | 37.76 Million |
| Depreciation & Amortization | 9.5 Million | 9.43 Million | 33.14 Million | 9.14 Million | 8.56 Million | 8.57 Million |
| Deferred income taxes | -1.61 Million | -1.74 Million | -17.81 Million | 883 Thousand | -13.94 Million | -3.23 Million |
| Stock-based compensation | 4.4 Million | 8.24 Million | 14.25 Million | 4.25 Million | 3.81 Million | 3.29 Million |
| Change in working capital | 8.64 Million | -8.64 Million | -37.32 Million | 7.65 Million | -3.61 Million | -15.7 Million |
| Other non-cash items | 23.69 Million | 153 Thousand | 79.93 Million | -1.12 Million | 81.06 Million | 65 Thousand |
| Investing Cash Flow | -10 Thousand | -199 Thousand | -293.5 Million | -38.31 Million | -92.81 Million | - |
| Investments in PPE | -10 Thousand | -199 Thousand | -198.52 Million | -36.09 Million | -79.35 Million | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -13.46 Million | - | -13.46 Million | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -81.51 Million | -2.22 Million | -79.28 Million | - |
| Financing Cash Flow | 1.15 Million | 141.04 Million | -10.85 Million | -665 Thousand | -10.12 Million | -214 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -296 Thousand | -982 Thousand | -453 Thousand | - | -52 Thousand |
| Common Stock Issuance | 2.03 Million | 141 Million | 2.79 Million | 693 Thousand | 212 Thousand | 617 Thousand |
| Other Financing Activities | -874 Thousand | -1.17 Million | -9.87 Million | -212 Thousand | -10.12 Million | -162 Thousand |
| Accounts receivables | 3.32 Million | -6.97 Million | -43.07 Million | -5.46 Million | -5.25 Million | -9.39 Million |
| Accounts payables | -3.14 Million | -4.53 Million | 10.82 Million | 10.19 Million | 177 Thousand | 1.03 Million |
| Inventory | 1.93 Million | -4.3 Million | -4.73 Million | -6.6 Million | 1.71 Million | -423 Thousand |
| Other working capital | 6.53 Million | 7.17 Million | -330 Thousand | 9.53 Million | -251 Thousand | -6.91 Million |
| Cash at beginning of period | 310.41 Million | 137.63 Million | 298.39 Million | 120.97 Million | 178.78 Million | 148.24 Million |
| Cash at end of period | 375.69 Million | 310.41 Million | 137.63 Million | 137.63 Million | 120.97 Million | 178.78 Million |
| Capital Expenditure | -10 Thousand | -199 Thousand | -198.52 Million | -36.09 Million | -79.35 Million | - |
| Effect of forex changes on cash | - | - | - | -61.25 Million | 61.25 Million | - |
| Net cash flow / Change in cash | 65.28 Million | 172.77 Million | -160.75 Million | 16.66 Million | -57.81 Million | 30.54 Million |
| Free Cash Flow | 64.12 Million | 31.72 Million | -54.92 Million | 19.55 Million | -34.22 Million | 30.75 Million |
ECM
CODI-PB
CNLPL
SYNX
BRNA
GRUMAB